feed,title,long_url,short_url
BioRxiv,"A semi-quantitative, rapid, point of care SARS-CoV-2 serologic assay predicts neutralizing antibody levels",https://biorxiv.org/cgi/content/short/2023.05.30.542314v1?rss=1,https://da.gd/UmCN7
BioRxiv,CD4+ T-cell immunity of SARS-CoV-2 patients determine pneumonia development,https://biorxiv.org/cgi/content/short/2023.05.31.543129v1?rss=1,https://da.gd/KSDFAd
